| progesterone / Generic mfg. |
NCT01441635: Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids |
|
|
| Completed | 2a | 271 | NA | Elagolix, ABT-620, Placebo, Estradiol/Norethindrone acetate (E2/NETA), Activella®, Estradiol, Estrace®, Progesterone, Prometrium® | AbbVie (prior sponsor, Abbott) | Heavy Uterine Bleeding, Uterine Fibroids | 11/13 | 05/14 | | |
|
NCT00255463: Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study |
|
|
| Completed | 2 | 185 | Europe | Anastrazole, Gefitinib | AstraZeneca | Breast Cancer | | 11/05 | | |
NCT00117468: Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement |
|
|
| Completed | 2 | 20 | US | DR-2011, Progesterone 8% Vaginal Gel, Crinone | Duramed Research | Infertility | 04/06 | 04/06 | | |
NCT00229697: Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study |
|
|
| Completed | 2 | 317 | US, Canada, Europe, RoW | Gefitinib, Iressa, Tamoxifen, Nolvadex | AstraZeneca | Breast Neoplasms | 12/06 | 06/15 | | |
NCT00196391: A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea |
|
|
| Completed | 2 | 180 | US | DR-2021a, Micronized progesterone, DR-2021b, Micronized Progesterone, DR-2021c, DR-2021d, DR-2021e, Placebo | Duramed Research | Amenorrhea | 04/07 | 04/07 | | |
| Completed | 2 | 125 | Europe, RoW | Barusiban, Atosiban, Placebo | Ferring Pharmaceuticals | In Vitro Fertilisation (IVF) Treatment | 05/08 | 09/08 | | |
| Completed | 2 | 52 | Europe | estetrol, estetrol and desogestrel, estetrol and progesterone | Pantarhei Bioscience | Healthy | 08/08 | 08/08 | | |
NCT00919919: Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen |
|
|
| Unknown status | 2 | 60 | RoW | progesterone, Endometrin, activella | Rabin Medical Center, Ferring Pharmaceuticals | Endometrial Hyperplasia, Endometrial Cancer | 09/10 | 11/10 | | |
NCT00580333: Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer |
|
|
| Completed | 2 | 51 | US | cisplatin, platinol, bevacizumab, Avastin, doxorubicin, adriamycin, cyclophosphamide, cytoxan, paclitaxel, taxol | Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Genentech, Inc. | Breast Cancer | 12/10 | 06/20 | | |
2014-001185-10: Effect on the endometrial thickness of progesterone 25 mg solution administered by oral route in post-menopausal women under treatment with estrogens, compared to progesterone 200 mg capsules. Effetto sullo spessore dell’endometrio di progesterone 25 mg soluzione somministrato per via orale in donne in post-menopausa in trattamento con estrogeni, in confronto con progesterone 200 mg capsule. |
|
|
| Terminated | 2 | 36 | Europe | PLEYRIS 25 mg solution for injection (in the protocol also designated Progesterone 25 mg solution), PROMETRIUM 200 mg soft capsules for oral and vaginal use, Solution for injection, Capsule, soft, PLEYRIS 25 mg solution for injection, PROMETRIUM 200 mg soft capsules for oral and vaginal use | IBSA Institut Biochimique SA, IBSA Institut Biochimique SA | hormone replacement therapy of menopause (as progestin therapy in association to estrogen replacement therapy) terapia ormonale sostitutiva della menopausa (come terapia progestinica da associare alla terapia estrogenica sostitutiva), hormone replacement therapy of menopause terapia ormonale sostitutiva della menopausa, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
NCT02225353: Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery |
|
|
| Completed | 2 | 271 | RoW | Progesterone Cervical Pessary 6.3 g, Progesterone 200 mg vaginal capsules, Hormoral (Trade Mark) Capsules, Progesterone Cervical Pessary 7.7 g | Grünenthal GmbH, Laboratorios Andromaco S.A. | Preterm Birth | 03/17 | 03/17 | | |
NCT02841137: Efficacy Study of Progesterone Tablet in Post-menopausal Women |
|
|
| Completed | 2 | 80 | Canada | Progesterone | IBSA Institut Biochimique SA | Menopause | 08/17 | 04/18 | | |
| Completed | 2 | 213 | Europe | Progesterone subcutaneous, Progesterone Vaginal Product | IBSA Institut Biochimique SA | Infertility | 09/22 | 12/22 | | |
| Active, not recruiting | 2 | 150 | Canada | Progesterone Effervescent Vaginal Tablet, Endometrin | Clinique Ovo, Ferring Pharmaceuticals | Fertility Issues, Embryo Implantation, Frozen Embryo Transfer | 09/25 | 06/26 | | |
NCT01057511: Compare the Difference of P4 Concentration in Serum and Endometrium After Vaginal and IM P Administration |
|
|
| Completed | 1/2 | 51 | RoW | Crinone 8%, progesterone vaginal gel, Progesterone, IMP | Peking Union Medical College Hospital, Merck Serono International SA | Postmenopausal Endometrium | 08/11 | 02/12 | | |
